Quantbot Technologies LP Takes Position in Avantor, Inc. (NYSE:AVTR)

Quantbot Technologies LP purchased a new position in Avantor, Inc. (NYSE:AVTR) in the second quarter, HoldingsChannel reports. The fund purchased 270,653 shares of the company’s stock, valued at approximately $5,738,000.

Several other institutional investors have also recently added to or reduced their stakes in AVTR. Versant Capital Management Inc raised its stake in shares of Avantor by 2,003.6% in the 2nd quarter. Versant Capital Management Inc now owns 1,157 shares of the company’s stock valued at $25,000 after purchasing an additional 1,102 shares in the last quarter. Blue Trust Inc. increased its stake in Avantor by 1,830.3% during the second quarter. Blue Trust Inc. now owns 1,467 shares of the company’s stock valued at $31,000 after purchasing an additional 1,391 shares during the last quarter. TFO Wealth Partners LLC grew its holdings in shares of Avantor by 203,100.0% during the fourth quarter. TFO Wealth Partners LLC now owns 2,032 shares of the company’s stock valued at $46,000 after purchasing an additional 2,031 shares during the last quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH bought a new stake in shares of Avantor in the 1st quarter worth approximately $93,000. Finally, ORG Partners LLC lifted its holdings in shares of Avantor by 5,773.0% in the 2nd quarter. ORG Partners LLC now owns 5,873 shares of the company’s stock worth $122,000 after purchasing an additional 5,773 shares during the last quarter. 95.08% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Avantor

In other Avantor news, CAO Steven W. Eck sold 3,525 shares of the firm’s stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $25.06, for a total value of $88,336.50. Following the completion of the sale, the chief accounting officer now owns 29,544 shares in the company, valued at approximately $740,372.64. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 1.50% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the company. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $31.00 target price on shares of Avantor in a research report on Monday, July 29th. Evercore ISI decreased their target price on shares of Avantor from $28.00 to $27.00 and set an “outperform” rating for the company in a research report on Tuesday, July 2nd. TD Cowen boosted their price target on shares of Avantor from $28.00 to $31.00 and gave the stock a “buy” rating in a research report on Monday, July 29th. Robert W. Baird raised their price objective on shares of Avantor from $26.00 to $27.00 and gave the company an “outperform” rating in a research report on Monday, July 29th. Finally, Morgan Stanley boosted their target price on shares of Avantor from $28.00 to $29.00 and gave the stock an “overweight” rating in a report on Monday, July 29th. Four analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat, Avantor has a consensus rating of “Moderate Buy” and an average target price of $27.40.

Avantor Price Performance

NYSE AVTR opened at $26.88 on Monday. The stock has a market capitalization of $18.27 billion, a PE ratio of 68.92, a P/E/G ratio of 2.75 and a beta of 1.32. The stock has a 50-day simple moving average of $24.42 and a 200 day simple moving average of $24.27. The company has a debt-to-equity ratio of 0.89, a quick ratio of 1.05 and a current ratio of 1.59. Avantor, Inc. has a twelve month low of $16.63 and a twelve month high of $28.00.

Avantor (NYSE:AVTR) last posted its quarterly earnings data on Friday, July 26th. The company reported $0.25 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.02. Avantor had a return on equity of 12.40% and a net margin of 5.28%. The company had revenue of $1.70 billion during the quarter, compared to analysts’ expectations of $1.70 billion. Research analysts anticipate that Avantor, Inc. will post 1.01 EPS for the current year.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.